Geron Corp. (GERN)
1.475
-0.02
(-1.01%)
USD |
NASDAQ |
Sep 01, 16:00
1.475
0.00 (0.00%)
After-Hours: 20:00
Geron Total Long Term Debt (Quarterly) : 250.76M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 250.76M |
| March 31, 2026 | 250.83M |
| December 31, 2025 | 250.57M |
| September 30, 2025 | 250.25M |
| June 30, 2025 | 248.82M |
| March 31, 2025 | 246.71M |
| December 31, 2024 | 245.54M |
| September 30, 2024 | 86.30M |
| June 30, 2024 | 86.08M |
| March 31, 2024 | 85.57M |
| December 31, 2023 | 84.95M |
| September 30, 2023 | 55.08M |
| June 30, 2023 | 55.14M |
| March 31, 2023 | 54.91M |
| December 31, 2022 | 54.83M |
| September 30, 2022 | 54.58M |
| June 30, 2022 | 54.40M |
| March 31, 2022 | 54.30M |
| December 31, 2021 | 54.10M |
| September 30, 2021 | 39.07M |
| June 30, 2021 | 38.96M |
| March 31, 2021 | 28.89M |
| December 31, 2020 | 28.84M |
| September 30, 2020 | 28.81M |
| June 30, 2020 | 4.991M |
| Date | Value |
|---|---|
| March 31, 2020 | 5.159M |
| December 31, 2019 | 2.20M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Precigen, Inc. | 97.29M |
| Editas Medicine, Inc. | 64.74M |
| Agenus, Inc. | 259.00M |
| Amgen, Inc. | 57.30B |
| Anika Therapeutics, Inc. | 23.32M |